United States - English - NLM (National Library of Medicine)

feelgood health - gelsemium sempervirens root (unii: 639kr60q1q) (gelsemium sempervirens root - unii:639kr60q1q), chocolate (unii: d9108tz9kg) (chocolate - unii:d9108tz9kg), graphite (unii: 4qqn74lh4o) (graphite - unii:4qqn74lh4o) - gelsemium sempervirens root 30 [hp_c] - indications: homeopathic remedy for confidence and calm in social situations (e.g. public speaking). contains no gluten, artificial flavors, colors or preservatives. safe for all ages and during pregnancy.

United States - English - NLM (National Library of Medicine)

native remedies, llc - cocoa (unii: d9108tz9kg) (cocoa - unii:d9108tz9kg), gelsemium sempervirens root (unii: 639kr60q1q) (gelsemium sempervirens root - unii:639kr60q1q), graphite (unii: 4qqn74lh4o) (graphite - unii:4qqn74lh4o) - reduces social fear and anxiety uses: homeopathic remedy for confidence and calm in social situations (e.g. public speaking)

United States - English - NLM (National Library of Medicine)

native remedies, llc - cocoa (unii: d9108tz9kg) (cocoa - unii:d9108tz9kg), gelsemium sempervirens root (unii: 639kr60q1q) (gelsemium sempervirens root - unii:639kr60q1q), graphite (unii: 4qqn74lh4o) (graphite - unii:4qqn74lh4o) - reduces social fear and anxiety uses: homeopathic remedy for confidence and calm in social situations (e.g. public speaking)

United States - English - NLM (National Library of Medicine)

lab-clean, inc - benzalkonium chloride (unii: f5um2km3w7) (benzalkonium - unii:7n6jud5x6y) - antimicrobial for hand sanitizing to decrease bacteria on the skin. recommended for repeated use.

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - cyproterone acetate, quantity: 50 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; maize starch; colloidal anhydrous silica; povidone - women: moderately severe to severe signs of androgenization. moderately severe/severe forms of hirsutism.moderately severe/severe androgen-dependent loss of scalp hair (moderately severe/severe androgenic alopecia). moderately severe/severe forms of acne and/or seborrhoea associated with other features of androgenization.cyproterone acetate inhibits the influence of male sex hormones which are also produced by the female. it is thus possible to treat diseases in women caused either by increased production of androgens or a particular sensitivity to these hormones. hirsutism and alopecia may be expected to recur over a period of time after cessation of treatment.if androcur is taken during pregnancy, the properties of the preparation may lead to signs of feminisation in the male foetus. therefore, in women of childbearing potential, pregnancy must be excluded at the commencement of treatment and ethinyloestradiol taken as well to ensure contraception. this also promotes regular menstruation.men:reduction of drive in sexual deviations androcur reduces the force of the sexual urge in men with sexual deviations. whilst under treatment the man can control himself better in a predisposing stimulatory situation, but there is no influence on any deviating direction of sexual drive. abnormal patterns of sexual behaviour require treatment when they are distressing to the patient. a pre-requisite for therapy is the desire by the patient for treatment.androcur therapy should be supplemented by psychotherapeutic and sociotherapeutic measures in order to exploit the period of reduced drive for personal and social re-orientation.inoperable prostatic carcinoma to suppress "flare" with initial lhrh analogue therapy in long term palliative treatment where lhrh analogues or surgery are ineffective, not tolerated, contraindicated or where oral therapy is preferred in the treatment of hot flushes in patients treated with lhrh analogues or who have had orchidectomy.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - venlafaxine as hydrochloride - capsules extended release - venlafaxine as hydrochloride 75 mg - venlafaxine - venlafaxine - for the treatment of depression. maintenance of recurrent depression. generalized anxiety disorder (gad) - short term and long-term. social anxiety disorder (sad).

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - venlafaxine as hydrochloride - capsules extended release - venlafaxine as hydrochloride 150 mg - venlafaxine - venlafaxine - for the treatment of depression. maintenance of recurrent depression. generalized anxiety disorder (gad) - short term and long-term. social anxiety disorder (sad).

European Union - English - EMA (European Medicines Agency)

h. lundbeck a/s - nalmefene hydrochloride dihydrate - alcohol-related disorders - drugs used in alcohol dependence - selincro is indicated for the reduction of alcohol consumption in adult patients with alcohol dependence who have a high drinking-risk level (see section 5.1), without physical withdrawal symptoms and who do not require immediate detoxification.selincro should only be prescribed in conjunction with continuous psychosocial support focused on treatment adherence and reducing alcohol consumption.selincro should be initiated only in patients who continue to have a high drinking-risk level two weeks after initial assessment.

European Union - English - EMA (European Medicines Agency)

indivior europe limited - buprenorphine, naloxone - opioid-related disorders - other nervous system drugs - substitution treatment for opioid-drug dependence, within a framework of medical, social and psychological treatment. the intention of the naloxone component is to deter intravenous misuse. treatment is intended for use in adults and adolescents over 15 years of age who have agreed to be treated for addiction.

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - escitalopram oxalate, quantity: 25.548 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; maize starch; magnesium stearate; mannitol; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 6000 - treatment of major depression. ,treatment of social anxiety disorder (social phobia). ,treatment of generalised anxiety disorder. ,treatment of obsessive-compulsive disorder.